|
|
amine metabolic process
|
GO:0009308 |
45 |
0.393
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.186
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.156
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.148
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.143
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.121
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.114
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.105
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.093
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.093
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.093
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.092
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.091
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.090
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.089
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.089
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.089
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.088
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.087
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.087
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.085
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.084
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.082
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.082
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.080
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.079
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.078
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.077
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.077
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.077
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.075
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.074
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.073
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.072
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.071
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.070
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.069
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.068
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.068
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.066
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.066
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.065
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.061
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.061
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.058
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.058
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.058
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.057
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.055
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.055
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.053
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.053
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.052
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.052
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.051
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.051
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.050
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.050
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.049
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.049
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.048
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.048
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.047
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.047
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.047
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.046
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.046
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.046
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.046
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.045
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.045
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.044
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.044
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.043
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.043
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.043
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.043
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.043
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.043
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.042
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.042
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.042
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.042
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.042
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.042
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.042
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.041
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.041
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.041
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.040
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.040
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.040
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.040
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.040
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.040
|
|
|
|
negative regulation of fibroblast growth factor production
|
GO:0090272 |
2 |
0.040
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.040
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.039
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.039
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.039
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.039
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.039
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.038
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.038
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.038
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.037
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.037
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.037
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.037
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.037
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.036
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.036
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.036
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.036
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.036
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.036
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.036
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.035
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.035
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.035
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.035
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.035
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.034
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.034
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.034
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.034
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.034
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.034
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.034
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.034
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.034
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.033
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.033
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.033
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.033
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.033
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.033
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.033
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.033
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.033
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.032
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.032
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.032
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.032
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.032
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.032
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.032
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.032
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.032
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.031
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.031
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.031
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.031
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.031
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.031
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.031
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.031
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.030
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.030
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.030
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.030
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.030
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.030
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.030
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.030
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.030
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.030
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.030
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.029
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.029
|
|
|
|
hematopoietic stem cell proliferation
|
GO:0071425 |
13 |
0.029
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.029
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.029
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.029
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.029
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.029
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.029
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.029
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.029
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.028
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.028
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.028
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.028
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.028
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.028
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.028
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.028
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.028
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.027
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.027
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.027
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.027
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.027
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.027
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.027
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.027
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.027
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.027
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.027
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.027
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.026
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.026
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.026
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.026
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.026
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.026
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.026
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.026
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.026
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.026
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.026
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.026
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.026
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.026
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.026
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.026
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.025
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.025
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.025
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.025
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.025
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.025
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.025
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.025
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.025
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.025
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.025
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.025
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.024
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.024
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.024
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.024
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.024
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.024
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.024
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.024
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.024
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.024
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.024
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.024
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.024
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.024
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.024
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.024
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.024
|
|
|
|
photoreceptor cell morphogenesis
|
GO:0008594 |
3 |
0.024
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.024
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.024
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.024
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.023
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.023
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.023
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.023
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.023
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.023
|
|
|
|
positive regulation of thyroid hormone generation
|
GO:2000611 |
2 |
0.023
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.023
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.023
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.023
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.023
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.023
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.023
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.023
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.022
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.022
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.022
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.022
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.022
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.022
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.022
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.022
|
|
|
|
interleukin 6 production
|
GO:0032635 |
58 |
0.022
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.022
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.022
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.022
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.022
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.022
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.022
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.022
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.022
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.022
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.021
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.021
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.021
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.021
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.021
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.021
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.021
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.021
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.021
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.021
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.021
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.021
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.021
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.021
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.021
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.020
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.020
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.020
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.020
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.020
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.020
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.020
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.020
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.020
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.020
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.020
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.020
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.020
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.020
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.020
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.020
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.020
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.020
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.020
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.020
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.020
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.020
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.019
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.019
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.019
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.019
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.019
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.019
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.019
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
4 |
0.019
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.019
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.019
|
|
|
|
regulation of interleukin 1 production
|
GO:0032652 |
26 |
0.019
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.019
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.019
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.019
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.019
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.019
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.018
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.018
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.018
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.018
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.018
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.018
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.018
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.018
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.018
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.018
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.018
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.018
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.018
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.018
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.017
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.017
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.017
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.017
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.017
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.017
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.017
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.017
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.017
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.017
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.017
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.017
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.017
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.017
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.017
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.017
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.017
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.017
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.017
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.017
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.017
|
|
|
|
cilium movement
|
GO:0003341 |
28 |
0.017
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.017
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.017
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.017
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.017
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.017
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.017
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.017
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.017
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.017
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.016
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.016
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.016
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.016
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.016
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.016
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.016
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.016
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.016
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.016
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.016
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.016
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.016
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.016
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.016
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.016
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.016
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.016
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.016
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.016
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.016
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.016
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.016
|
|
|
|
loop of henle development
|
GO:0072070 |
10 |
0.016
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.016
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.016
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.016
|
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.016
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.016
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.016
|
|
|
|
regulation of b cell mediated immunity
|
GO:0002712 |
37 |
0.016
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.016
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.016
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.016
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.016
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.016
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.016
|
|
|
|
fungiform papilla development
|
GO:0061196 |
6 |
0.016
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.016
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.016
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.015
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.015
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.015
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.015
|
|
|
|
white fat cell differentiation
|
GO:0050872 |
15 |
0.015
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.015
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.015
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.015
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.015
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.015
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.015
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.015
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.015
|
|
|
|
metanephric nephron tubule development
|
GO:0072234 |
16 |
0.015
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.015
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.015
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.015
|
|
|
|
negative regulation of b cell activation
|
GO:0050869 |
27 |
0.015
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.015
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.015
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.015
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.015
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.015
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
40 |
0.015
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.015
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.015
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.015
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.015
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.015
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.015
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.015
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.015
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.015
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.014
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.014
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.014
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.014
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.014
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.014
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.014
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.014
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.014
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.014
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.014
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.014
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.014
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.014
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.014
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.014
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.014
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.014
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.014
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.014
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.014
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.014
|
|
|
|
male anatomical structure morphogenesis
|
GO:0090598 |
4 |
0.014
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.014
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.013
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.013
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.013
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.013
|
|
|
|
branch elongation of an epithelium
|
GO:0060602 |
19 |
0.013
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.013
|
|
|
|
chondroitin sulfate metabolic process
|
GO:0030204 |
17 |
0.013
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.013
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.013
|
|
